Tiervlei Trial Center   Report issue

For profit Phase 2
Founded: Cape Town South Africa (2000)
Status: No NME R&D (2000)

Organization Overview

First Clinical Trial
2006
NCT00401271
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

delamanid (1 trial)

pyrazinamide (Aldinamide) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Tuberculosis (Phase 2)

Tuberculosis, Pulmonary (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2